stockrowLeMaitre Vascular, Inc.
LMAT Healthcare Medical Instruments & Supplies
LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.
- Revenue
- +11.3%
- EPS
- −14.3%
- Free cash flow
- −25.8%
- Total debt
- +0.53%
Quarter to September 2026, against a year earlier
Follow LMAT
Alert me
LeMaitre Vascular, Inc. (LMAT) Current ratio
LeMaitre Vascular, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 14.6×, up 1.7× from fiscal 2025 (12.9×). Over the past ten years it has ranged from 3.7× (fiscal 2020) to 13.1× (fiscal 2024); the current reading is higher than 91% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 12.9× | (1.90%) |
| FY2024 | 13.1× | 101.76% |
| FY2023 | 6.5× | 2.00% |
| FY2022 | 6.4× | (0.43%) |
| FY2021 | 6.4× | 71.06% |
| FY2020 | 3.7× | (15.12%) |
| FY2019 | 4.4× | (7.18%) |
| FY2018 | 4.8× | (21.86%) |
| FY2017 | 6.1× | 8.13% |
| FY2016 | 5.6× | 0.35% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 14.6× | (10.48%) |
| Jun 2026 | 16.3× | 13.92% |
| Mar 2026 | 14.3× | 11.08% |
| Dec 2025 | 12.9× | (5.07%) |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| LMAT LeMaitre Vascular, Inc. | 14.6× |
| PLSE Pulse Biosciences, Inc compare | 14.3× |
| KMTS Kestra Medical Technologies, Ltd. compare | 4.7× |
| STAA STAAR Surgical Company compare | 4.7× |
| ATRC AtriCure, Inc. compare | 4.3× |
| AZTA Azenta, Inc. compare | 2.5× |
| WRBY Warby Parker Inc. compare | 2.3× |
| STVN Stevanato Group S.p.A. compare | 1.7× |
| XRAY DENTSPLY SIRONA Inc. compare | 1.6× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on LMAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement